| pubmed-article:8327178 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C0521362 | lld:lifeskim |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C0700364 | lld:lifeskim |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C0262926 | lld:lifeskim |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C0085970 | lld:lifeskim |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C0332119 | lld:lifeskim |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:8327178 | lifeskim:mentions | umls-concept:C1517067 | lld:lifeskim |
| pubmed-article:8327178 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:8327178 | pubmed:dateCreated | 1993-8-11 | lld:pubmed |
| pubmed-article:8327178 | pubmed:abstractText | Authors refer results obtained in 24 cases of primary NHL of gastrointestinal tract. These cases were observed in the period 1981-1990. All cases can be included as primary extranodal lymphomas satisfying criteria of the literature. Sixty-six per cent (16/24) had a gastric localization half cases were centrocytic-centroblastic lymphomas followed by immunoblastic, centroblastic, follicular centrocytic-centroblastic and lymphocytic-well-differentiated. In intestinal localisation (34% of cases), the most represented was lymphocytic poor-differentiated, followed by mixed centrocytic lymphoma. Therapeutic strategy was: surgery in all patients followed by chemotherapy (CHOP 14/24) or by radiotherapy plus chemotherapy (8/24). Surgery alone was adopted in 2 out 24 patients. Patients who received radiotherapy plus chemotherapy had a sandwich treatment (CVP = 4/8, CHOP = 4/8) consisting of splint course of 3 cycles followed by radiotherapy and completed with other 3 drugs cycles. Sixteen out 24 patients were valuable (4 patients were lost during the follow-up due to problems other than the disease; 4 patients are still under treatment). In the 16 valuable patients we had a complete remission (CR) with a median free-disease survival of 82 months (range: 12-116 months) by means of the primary treatment. Four out 16 patients relapsed. In these patients the free-disease survival was range 8-108 months. All patients reached a second CR by means of chemotherapy (CCNU + VIP16) or radiotherapy. No cases of second tumor insorgence was observed. | lld:pubmed |
| pubmed-article:8327178 | pubmed:language | ita | lld:pubmed |
| pubmed-article:8327178 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8327178 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8327178 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8327178 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8327178 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8327178 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8327178 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8327178 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:8327178 | pubmed:issn | 0026-4733 | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:SimonGG | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:BuddEE | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:Buff | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:RussoFF | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:La TorreFF | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:BellomoRR | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:BinottoFF | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:MandolitiGG | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:CroattoTT | lld:pubmed |
| pubmed-article:8327178 | pubmed:author | pubmed-author:DuchiMM | lld:pubmed |
| pubmed-article:8327178 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8327178 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8327178 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:8327178 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8327178 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8327178 | pubmed:pagination | 325-30 | lld:pubmed |
| pubmed-article:8327178 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:meshHeading | pubmed-meshheading:8327178-... | lld:pubmed |
| pubmed-article:8327178 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8327178 | pubmed:articleTitle | [Case histories of extranodal non-Hodgkin's lymphomas with primary gastrointestinal appearance]. | lld:pubmed |
| pubmed-article:8327178 | pubmed:affiliation | Ospedale Civile S. Maria dei Battuti, Regione Friuli-Venezia Giulia--USL 9, Sanvitese. | lld:pubmed |
| pubmed-article:8327178 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8327178 | pubmed:publicationType | English Abstract | lld:pubmed |
